SBF2 and nonpapillary renal cell carcinoma: Kaplan–Meier survival analysis showed that patients in the high SBF2-AS1 expression group had worse overall survival (OS) than those with low SBF2-AS1 expression, except for those with clear cell renal cell carcinoma (ccRCC) (Table 1).